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Open access under CC BY-NC-ND license.Results: Participants with higher hostility scores had heightened
systolic and diastolic blood pressure (BP) reactivity to tasks (both
Pb.05), as well as a more sustained increase in systolic BP at 2 h
post-task (P=.024), independent of age, BMI, smoking status,
medication, and baseline BP. Hostility was also associated with
elevated plasma interleukin-6 (IL-6) levels at 75 min (P=.023) and
2 h (P=.016) poststress and was negatively correlated with salivary
cortisol at 75 min (P=.034). Conclusion: Hostile individuals with
advanced cardiovascular disease may be particularly susceptible to
stress-induced increases in sympathetic activity and inflammation.
These mechanisms may contribute to an elevated risk of
emotionally triggered cardiac events in such patients.
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Acute coronary syndromes (ACS), defined as ST-segment
elevation myocardial infarction (STEMI), non-ST-segment
elevation MI (NSTEMI), and unstable angina (UA), cause
significant morbidity and mortality in industrialized societies
[1]. Growing evidence from clinical studies using case cross-
over analysis suggests that acute episodes of anger cantrigger ACS in people with advanced coronary disease, with
the period 1–2 h prior to symptom onset being particularly
hazardous [2–5].
Hostility is an enduring personality trait that includes
emotional (anger) as well as attitudinal (cynicism and
mistrust of others) and behavioral (overt and repressed
aggression) components [6], and numerous cross-sectional
and prospective studies have highlighted hostility as a robust
independent risk factor for coronary artery disease (CAD)
and all-cause mortality in humans [7–11]. Findings relating
hostility with adverse clinical outcomes in CAD patients
have been somewhat less consistent [12]. However, a recent
meta-analysis including 19 prospective studies of men and
women with existing coronary disease found a significant
independent association between hostility and risk of future
cardiac events in these patients [11]. 
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tional triggering of acute cardiac events are poorly under-
stood. Atherosclerosis is a chronic inflammatory process
involving the progressive recruitment and activation of
leukocytes, lipid, platelets, and smooth muscle cells in the
endothelial lining of coronary arteries, resulting in the
formation of a fibrous plaque that protrudes into the arterial
lumen. ACS occur when there is a rupture of vulnerable
plaque and consequent activation and aggregation of
platelets, leading to the formation of a blood clot (thrombus)
that occludes the artery and prevents blood flow to the heart
[13]. Emotional stress activates the sympathetic nervous
system (SNS) and the hypothalamic-pituitary-adrenal axis,
resulting in respective increases in blood pressure (BP) and
circulating levels of catecholamines and glucocorticoids
(cortisol) [14]. Acute elevations in BP can provoke plaque
rupture by disrupting blood flow across the diseased vessel
and increasing endothelial shear stress [15], and glucocorti-
coids regulate a number of processes involved in plaque
stability including vascular endothelial function and inflam-
mation [16]. Circulating levels of inflammatory cytokines
are also up-regulated during stress, and these molecules play
a pivotal role in plaque rupture and thrombosis [15,17].
There is considerable evidence that healthy hostile
individuals have heightened or prolonged cardiovascular
and neuroendocrine responses to acute emotional stress [18].
However, studies relating hostility and inflammatory stress
responses are sparse. Furthermore, little is known about the
role of hostility in acute stress responses in patients with
advanced cardiovascular disease. We set out to address these
issues by investigating the relationship between trait hostility
and physiological responses to laboratory stress in a sample
of patients who had recently survived an ACS. We predicted
that patients with elevated hostility scores would be more
responsive to stress.Methods
Participants
Thirty-four men who had recently survived an ACS were
included in this study, details of which are reported
elsewhere [19]. Participants were a subsample from the
ACCENT study, an investigation of 295 patients admitted
with ACS to four hospitals in the London area [5]. Inclusion
criteria for the ACCENT study were as follows: a diagnosis
of ACS based on the presence of chest pain plus verification
by diagnostic electrocardiogram (EKG) and/or cardiac
enzyme changes; the ability to recall a specific time of
symptom onset and to complete a research interview in
English; age between 18 and 90 years; and the absence of
comorbid conditions that could influence either symptom
presentation, mood, or troponin positivity (including severe
psychiatric illness, ongoing infection, or inflammatory
conditions). Patients were classified on the basis of EKGand biochemical markers to the different forms of ACS.
Primary treatments were classified as percutaneous cor-
onary intervention (PCI), medical, or coronary artery bypass
graft (CABG).
For the current experiment, patients were recruited on
average 444.9±172 days post-ACS. This time interval was
selected to ensure that the patients' clinical condition had
stabilized. Patients who had experienced a second ACS or
cardiac intervention during the previous 6 months or had
severely impaired left ventricular function (b40%) or
ongoing symptoms of chest pain or breathlessness were
excluded. Patients who were aged over 80, were hyperten-
sive, taking antidepressants, color blind, had a history of late
ventricular dysrhythmia, atrial fibrillation, or developed new
comorbidities that could affect hemodynamic or inflamma-
tory measures were also excluded. Since the ACCENT study
included an insufficient number of women, only men were
included in the current investigation. There were 231 men in
the ACCENT study, of whom three were N80 years old, and
21 experienced onset of ACS after they had been asleep for
at least 2 h, so could not provide information about the
circumstances surrounding ACS onset, an additional focus of
our research [19]. Of the remainder, 12 lived outside the
country or too far away for participation; 50 were
hypertensive; five were deceased; 14 were lost to follow-
up; 44 had relevant comorbidities, persisting symptoms, or
very poor left ventricular function; and one was blind. Of the
82 subjects eligible for participation, 34 were tested in the
time available to complete the study. Patients who
participated in psychophysiological stress testing were
younger on average than those who were excluded
(P=.023) but did not differ in clinical presentation, medical
management, number of diseased coronary arteries, or other
cardiological or sociodemographic characteristics. All
patients gave written consent, and the study was approved
by the medical research ethics committees of University
College London Hospital, St. George's Hospital, and
Southend Hospital, in London.
Psychological measures
Hostility was measured using a 39-item abbreviated
version of the CookMedley Hostility Scale (CMHS) [6]. The
CMHS is the most widely used self-reported measure of
hostility and is reported to have good psychometric proper-
ties including adequate internal validity, good test–retest
reliability, and construct validity [20,21]. Each item was
scored on a four-point scale from 1=strongly disagree to
4=strongly agree, and measured trait tendencies towards
cynical, mistrustful attitudes towards others, and, to a lesser
extent, the individual's propensity for aggressive responding
and experiencing hostile affects. Total scores could range
from 39 to 156, with higher scores indicating greater
hostility, and the Cronbach α in this sample was 0.90.
Anxiety and depression were assessed using the Hospital
Anxiety and Depression scale, a well-validated instrument
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[22]. Each scale consists of seven items rated on four-point
scales, and total scores can range from 0 to 21. Cronbach α
scores were 0.80 and 0.77 for the anxiety and depression
scales, respectively.
Laboratory stress testing procedure
Participants were tested individually in the morning,
commencing at 9 a.m. They were instructed to avoid eating a
high-fat or high-protein breakfast, and to refrain from
caffeinated beverages, alcohol, and excessive exercise
during the 12 h prior to the session. Following consultation
with physicians, 18 patients were withdrawn from medica-
tion prior to the session and stopped taking aspirin 10 days
before testing and β-blockers, statins, or angiotensin-
converting enzyme (ACE) inhibitors 72 h before testing.
The remaining 16 continued to take some form of medication
at the time of testing (Table 1).
Anthropometric measures were obtained using standar-
dized methods, then participants were seated comfortably
and fitted with finger cuffs so that BP and heart rate could
be continuously monitored using a Portapres-2 device
(TNO-TPD Biomedical Instrumentation, Amsterdam, Hol-
land) [23]. A venous cannula was inserted in the lower arm
for blood sampling, and the participant rested for 30 min.
Blood pressure and heart rate were recorded for the last 5
min of the rest period, after which participants provided a
salivary cortisol sample, and a baseline blood sample was
drawn. Participants then completed two 5-min behavioral
tasks, administered in a fixed order. The first was aTable 1
Participant characteristics (N=34)
Age 55.9±9.3
Ethnicity (white European) 29 (85.3 %)
Education level
Less than high school 22 (64.7%)
High school, college 12 (35.3%)
Body mass index (kg/m2) 29.4±4.1
Waist–hip ratio 1.01±0.51
Cook Medley Hostility 91.0±11.8
Depression 3.88±3.3
Anxiety 5.03±3.4
Current smokers 7 (20.6%)
Number of diseased vessels 1.5±0.79
ACS
STEMI 24 (70.6%)
NSTEMI and UA 10 (29.4%)
Treatment
Medical 5 (15.2%)
PCI 23 (69.7%)
CABG 5 (15.2%)
β-Blockers at time of testing 16 (47.1%)
Statins at time of testing 11 (32.4%)
ACE inhibitors at time of testing 8 (23.5%)
Aspirin at time of testing 11 (32.4%)
Values are means±standard deviations, and numbers (percentages) for
categorical variables.computerized color-word interference task, involving the
successive presentation of target color words printed in an
incongruous color. The task was to press a computer key
that corresponded to the position at the bottom of the screen
of the name of the color in which the target word was
printed. The second task was presented after an interval of 5
min and involved simulated public speaking. Participants
were presented with a hypothetical scenario in which they
had been wrongly accused of shoplifting and were
instructed to give a speech in their defense. They were
told that their speech would be video recorded and later
judged for efficacy and fluency. Five-minute recordings of
BP and heart rate were made during each of the tasks, and a
second cortisol and blood sample were obtained immedi-
ately after the second task. Participants then rested quietly
for the remainder of the session. They were asked to rate
subjective feelings of stress on a seven-point scale from
1=low to 7=high at baseline (towards the end of the rest
period), following each of the tasks and then at 25, 70, and
115 min post-task. Ratings of task difficulty, controllability,
and involvement were also made after each task on seven-
point scales. Further recordings of BP and heart rate were
made at 25–30, 70–75, and 115–120 min post-tasks, and
blood samples were obtained at 30, 75, and 120 min post-
tasks. Salivary cortisol was sampled at 15, 30, 75, and 120
min post-tasks.
Cortisol measurement
Saliva samples were collected using Salivettes (Sarstedt,
Leicester, UK) and stored at −80°C prior to analyses.
Salivary cortisol was analyzed in randomized, duplicate
samples using a commercially available time-resolved
immunoassay with chemiluminescence detection (CLIA;
IBL-Hamburg, Hamburg, Germany), at the Technical
University of Dresden, Germany. This assay had a detection
limit of 0.16 ng/ml and intra- and interassay coefficients of
variation (CVs) of b10% and b12%, respectively. The
experimenter performing the assay was blinded to participant
details. Salivary cortisol levels are highly correlated with
circulating levels of free cortisol and are routinely used as a
biomarker of psychological stress [24].
Interleukin-6 measurement
Whole blood (10 ml) samples were drawn using 21-gauge
Butterfly needles into Vacutainer tubes containing EDTA as
anticoagulant, then centrifuged immediately at 1250×g for
10 min at room temperature. Plasma was removed, aliquoted,
and frozen at −80°C prior to analysis. Plasma interleukin-6
(IL-6) concentrations were assessed in randomized, dupli-
cate samples using a high-sensitivity two-site ELISA from
R&D Systems (Oxford, UK). The detection limit of this
assay was 0.09 pg/ml, with intra- and interassay CVs of 5.3%
and 9.2%, respectively. The experimenter running this assay
was blinded to participant details.
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All analyses were performed using SPSS version 14.0
(SPSS, Chicago, IL, USA). Some data were lost due to
equipment or assay failures, so analyses were performed on
32 patients for cortisol and 31 patients for BP, heart rate,
and IL-6. Other variables were measured in all 34
participants. Responses to mental stress testing were
analyzed using repeated measures analysis of variance,
with post hoc comparisons using Tukey's LSD test.
Cardiovascular variables were analyzed across five trials
(baseline, task, 30 min, 75 min, and 120 min), IL-6 across
four trials (baseline, 30 min, 75 min, and 120 min post-
task), and cortisol across six trials (baseline; immediately
post-task; and 15, 30, 75, and 120 min post-task).
Associations with hostility were analyzed using multiple
regression. For baseline measures, hostility was entered into
the regression models along with age, BMI, smoking status,
and medication status as covariates. The use of medications
was overlapping, since all patients who were taking aspirin,
statins, or ACE inhibitors were also taking β-blockers.
Consequently, medication status was indexed by the use of
β-blockers. Replacing BMI with waist/hip ratio as an
indicator of adiposity did not alter the results. Associations
of hostility with stress reactivity and recovery involved
regressions onto changes between baseline and task or post-
task values, and included the baseline level of the
dependent variable as an additional covariate. All tests
were two tailed.Results
Participant characteristics
Participant characteristics are presented in Table 1. Men
in this study had a mean age of 55.9 (S.D. 9.3). They were
predominantly white, with a limited education level. A
significant number were overweight and approximately one
fifth smoked. Twenty-four participants (70.6%) were
admitted with STEMI and the remainder with NSTEMI or
UA. Several participants continued to take medication at the
time of testing with just under half on β-blockers, around a
quarter on ACE inhibitors, and approximately one third onTable 2
Cardiovascular, inflammatory, and subjective stress responses
Baseline Tasks Immediately post-task 1
Systolic BP (mmHg) 118.6±3.8a 151.9±4.3b
Diastolic BP (mmHg) 74.7±2.0a 91.5±2.2b
Heart rate (bpm) 62.8±1.9a 71.0±2.2b
IL-6 (pg/ml) 1.96±0.21a
Cortisol (nmol/l) 7.99±0.81a 10.38±1.1b 1
Subjective stress rating 1.61±0.16a 3.77±0.17b
Values are means±S.E. Stress responses were analyzed using repeated measures an
in rows with different superscripts are significantly different from one another (Pstatins or aspirin. Participants' mean score on the CMHS was
91.0 (S.D. 11.8). Hostility was not related to age, education
level, ethnicity, BMI, waist–hip ratio, or smoking status, nor
was it related to clinical variables including type of ACS,
number of diseased vessels, treatment plan, or medication
status at the time of testing. Hostility scores were positively
correlated with depression (r=0.38, P=.029) but not with
anxiety (r=0.22, P=.23).
Stress responses
Details of participants' subjective and physiological stress
responses are presented in Table 2. Participants rated both
tasks as difficult and involving, withmean ratings of 5.26±1.3
and 5.35±1.4, respectively, for the color-word and 4.50±1.4
and 4.38±1.9 for the speech task. There were significant main
effects of trial for perceived stress levels [F(4,128)=63.6,
Pb.001], systolic BP [F(4,120)=32.3, Pb.001], diastolic BP
[F(4,120)=25.4, Pb.001], heart rate [F(4,116)=50.4,
Pb.001], and cortisol [F(5,155)=19.1, Pb.001]. Perceived
stress levels increased during each of the tasks, returning to
low levels during recovery. Participants' BP also increased
significantly during tasks, with an average rise of 33.3±18.8
mmHg in systolic BP and 16.8±9.4 mmHg in diastolic BP,
respectively. Both systolic and diastolic BP remained
elevated above baseline levels during the 2-h recovery
period. Similarly, heart rate increased substantially in
response to tasks, with an average rise of 8.2±5.5 bpm.
There were large individual differences in cardiovascular
stress responses with changes in systolic BP ranging from
−17.8 to +73.91 mmHg during tasks and from −19.8 to +29.9
mmHg at 2 h post-task. Similarly, diastolic BP responses
ranged from −5.11 to +42.6 mmHg during tasks. Salivary
cortisol levels increased following tasks, peaking at 15 min
post-task. Although the average increase in plasma IL-6 was
not significant, there were marked individual differences in
this response, with changes in IL-6 ranging from −1.38 to
+1.56 pg/ml at 75 min and −1.34 to +1.68 pg/ml at 120 min
poststress. There were no significant associations between
IL-6 measures and any of the cardiovascular responses.
However, there was an inverse relationship between cortisol
and IL-6 responses; the cortisol change at 75 min was
inversely correlated with increases in IL-6 at 75 min (r=
−0.49, P=.009) and 120 min (r=−0.51, P=.006).5 min post-task 30 min post-task 75 min post-task 120 min post-task
133.0±4.3c 135.0±4.3c 128.0±4.1c
84.0±2.1c 85.3±2.2c 82.5±2.2c
61.1±1.8c 61.4±1.7c 60.6±1.7c
2.16± 0.23a 2.30±0.28a 2.23±0.24a
3.36±1.6c 8.98±0.95a,b 5.30±0.42d 5.36±0.62d
1.61±0.16a 1.30±0.13a 1.39±0.17a
alysis of variance, with post hoc comparisons using Tukey's LSD test. Trials
b.05).
Fig. 2. Changes in plasma IL-6 concentrations between baseline and 75 min
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physiological parameters
There was no association between hostility and baseline
levels of subjective stress, BP, heart rate, salivary cortisol, or
plasma IL-6 concentrations. However, multiple regression
analysis revealed a significant relationship between trait
hostility and systolic BP reactivity to tasks (β=0.358,
P=.048). The variance accounted for by the complete
model (r2) was 0.32, and the variance accounted for by
hostility (Δr2) was 0.11. A similar relationship was found
between hostility and diastolic BP reactivity to tasks
(β=0.476, P=.007, r2=0.37, Δr2=0.21). These associations,
illustrated in Fig. 1, were independent of age, BMI, smoking
status, medication at the time of testing, and baseline levels
of the respective dependent variable. Hostility was not
related to either heart rate reactivity or cortisol reactivity.
Regression analyses also revealed a significant associa-
tion between hostility and prolonged increases in systolic BP
at 2 h post-task (β=0.400, P=.024, r2=.38, Δr2=0.15) and
between hostility and elevated plasma IL-6 concentrations at
both 75 min post-task (β=0.309, P=.023, r2=.63, Δr2=0.09)
and 2 h post-task (β=0.327, P=.016, r2=.64, Δr2=0.10). By
contrast, hostility was negatively correlated with cortisol
levels at 75 min post-task (β=−0.325, P=.034, r2=.64,
Δr2=0.10) and was unrelated to heart rate recovery. As
above, all associations were independent of age, BMI,Fig. 1. Changes in systolic BP (upper panel) and diastolic BP (lower panel)
between baseline and task trials in relation to hostility scores.
(upper panel) and 2 h (lower panel) in relation to hostility scores.smoking status, medication at the time of testing, and
baseline levels of the respective dependent variable. The
relationship between hostility and IL-6 responses is
illustrated in Fig. 2, showing larger increases in IL-6 at 75
and 120 min post-task in more hostile individuals.
There was no association between hostility and subjective
task appraisal, or ratings of perceived stress, or between
subjective stress responses and BP or cytokine responses,
indicating that heightened/prolonged stress reactivity in
high-hostile men was not due to differences in the subjective
experience of the tasks. Similarly, depression and anxiety
had no impact on the associations between hostility and
biological responses (data not shown).Discussion
One of the main findings of our study was that ACS
patients scoring higher on the CMHS had larger increases in
systolic and diastolic BP during acute laboratory stress, as
well as a sustained increase in systolic BP following
cessation of the stress. These results add to the large body
of previous research demonstrating excessive and prolonged
cardiovascular reactivity to stressful situations among
healthy hostile individuals. Specifically, studies have
shown that high hostile men and women display larger
increases in BP and heart rate as well as elevated circulating
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acute laboratory stressors [18,25–27]. Our study extends
these observations to a diseased patient sample.
The other main study finding was that hostile ACS
patients had heightened poststress levels of IL-6. This
suggests that hostility may promote inflammation, although
the cross-sectional design prevents causal conclusions from
being drawn. A number of previous reports have found
positive correlations between hostility and basal circulating
levels of IL-6 in healthy humans. Total CMHS scores were
associated with elevated plasma IL-6 concentrations in a
small study of healthy men [28]. More recently, a larger
cross-sectional analysis of 6814 adults aged 45–84 years
found a positive graded relationship between serum IL-6 and
scores of cynical distrust, a component of hostility assessed
using a subscale of the CMHS [29], and comparable
associations were observed between circulating IL-6 and
scores on the hostile affect, cynicism, and aggressive
responding subscales of the CMHS in samples of middle-
aged men and women [30,31]. However, results have been
variable, with some studies reporting no association between
hostility and IL-6 levels in healthy adults [32], and others
reporting an association only in individuals with concur-
rently high or low levels of depressive symptoms [33–35]. In
the present investigation, hostility was unrelated to basal IL-
6 concentrations and the association between hostility and
IL-6 stress responses was independent of depressive
symptoms. Differences between study findings may be due
to heterogeneity in the hostility measure used, the specific
population studied and/or the presence of other moderating
psychosocial factors. To our knowledge, only one previous
investigation has examined the relationship between hostility
and inflammatory stress responses. Kiecolt-Glaser et al. [36]
found that couples with a high frequency of hostile marital
interactions, ‘high-hostile couples’, developed larger
increases in plasma levels of IL-6 and TNFα the morning
after a conflictual interaction task, compared with low-
hostile couples. Supporting our findings, these results
suggest that hostile individuals may be more susceptible to
stress-induced inflammation.
The mechanisms driving the association between hostility
and acute stress responses are unclear. Excessive sympa-
thetic nervous activity has been linked to β-adrenergic
receptor (β-AR) down-regulation in animals, and a number
of studies have related hostility to blunted cardiac and
vascular β-AR sensitivity in humans [37,38]. Since β-AR
activation plays a central role in the healthy vasodilatory
response of blood vessels to stress, a blunted adrenergic
response, promoting vasoconstriction, would result in an
increase in total peripheral resistance and elevated BP. There
is also evidence for diminished stress-induced parasympa-
thetic nervous activity in hostile individuals, and this
‘autonomic imbalance’ likely contributes to heightened
cardiovascular reactivity, due to a reduction in cardiac
autonomic control [27,39]. Lastly, glucocorticoids inhibit
inflammatory cytokine production by monocytes [16] andevidence suggests that high cortisol responders have smaller
inflammatory cytokine responses to acute psychological
stress [40]. In the current investigation, hostile patients had
lower cortisol levels at 75 min poststress, and cortisol
responses were inversely related to IL-6 stress responses.
Thus diminished cortisol levels in hostile patients might also
facilitate a heightened inflammatory response.
Prospective evidence in healthy humans has shown that
heightened and/or prolonged BP reactivity to acute labora-
tory stress is predictive of future hypertension and progres-
sion of preclinical cardiovascular disease states [41,42].
However, the data relating acute stress reactivity with
clinical CAD are less convincing, and most studies in
healthy individuals have found no relationship between BP
responses and future cardiac events or mortality [41]. Acute
cardiovascular and inflammatory stress responses may be
more relevant in people with advanced cardiovascular
disease. Evidence suggests that, whereas healthy coronary
vessels dilate in response to stress-induced SNS activation,
atherosclerotic vessels constrict, leading to increased
peripheral vascular resistance and myocardial ischemia
[43]. In addition, IL-6 stimulates a number of key processes
that contribute to plaque rupture and thrombosis including
macrophage production of matrix metalloproteinases
(enzymes that degrade the plaque's protective fibrous cap),
monocyte production of tissue factor (a key initiator of blood
coagulation in ACS), and hepatic synthesis of fibrinogen (an
acute phase protein central to blood coagulation and platelet
aggregation) [13,44]. Plasma IL-6 levels are significantly
elevated in ACS patients compared to patients with stable
CAD or healthy age-matched controls [45,46], and blood IL-
6 levels assessed at or near to the time of hospital admission
are a significant independent predictor of subsequent
coronary events and mortality [46,47].
The number of patients suitable for this investigation was
limited and the sample size was small. We therefore decided
not to randomize patients to stress and control conditions but
to apply the stressors to all participants. We and others have
previously shown that repeated measurements or the passage
of time in the absence of behavioral tasks does not lead to
elevations of cardiovascular and inflammatory markers
[15,17]. Nevertheless, it would have been preferable to
include a comparison control group of healthy individuals
without ACS, to test whether our observed associations
between hostility and stress responses were specific to (or
strengthened by) the presence of advanced CAD. The
majority of participants were poorly educated men of white
European origin, and results may not apply to other groups.
Several were overweight and current smokers, and the
analysis was complicated by the inclusion of patients whose
medications had been withdrawn and those individuals who
continued to take medication at the time of testing. A number
of previous studies examining the effects of medication on
physiological stress reactivity in humans found no effect of
aspirin or β-blockers on either cardiovascular or cortisol
responses to stress [48–50]. However, one recent study
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an effect of medication on stress reactivity cannot be
excluded. Due to the cross-sectional nature of our study,
the directionality of the relationship between hostility and
cardiovascular and cytokine responses cannot be determined.
The laboratory tasks used were not optimal for evoking
anger, and it would have been useful to include a measure of
state anger, given the evidence relating anger and emotional
triggering of ACS. Lastly, the CMHS is a self-report measure
and there is evidence that other hostility measures such as
behavioral ratings or ratings by significant others may have
more predictive utility in studies relating personality and
cardiovascular risk [9,51].
To our knowledge, this is the first study to directly
associate hostility with inflammatory and cardiovascular
stress responses in ACS patients. Our findings indicate that
hostile individuals with advanced cardiovascular disease are
particularly susceptible to stress-induced increases in
sympathetic activity and inflammation. These mechanisms
may contribute to an elevated risk of emotionally triggered
cardiac events in such patients.
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